Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

Inclusion Criteria: 1. Men and women≥18 years, \<65 years; 2. Lymphoma patients treated by autologous stem cell transplantation for the first time; 3. ECOG ≤ 2; 4. Ccr ≥ 50 ml/min; 5. ALT, AST and TBIL≤2.5-fold upper normal range; 6. Satisfactory heart and lung function; 7. Women of reproductive potential must have a negative pregnancy test. Male and female of reproductive potential must agree to practice birth control during the study and one year post study; 8. Good compliance and sighed informed consent voluntarily. Patients should be conformed to all inclusion criteria above. Exclusion Criteria: 1. Prior autologous/ allogeneic hematopoietic stem cell transplantation for lymphoma; 2. Senior or uncontrolled virus injection: HIV, TP, hepatitis virus; 3. Serious complications; 4. LVEF\<55%; 5. Atopy or allergy to biological product derived from colibacillus; 6. Women who are breastfeeding, pregnant or refused to practice contraception; 7. Severe mental or nervous system diseases; 8. Severe abnormalities of heart, lung and central nervous system symptoms; 9. Patients with sickle cell disease, erythronoclastic anemia or other hematological disease which has an impact on medullary hematopoiesis; 10. Enrolled in other study currently or 30 days before screen; 11. Patients, in the opinion of investigators, may not be eligible or are not able to comply with the study. Patients conformed to any of above criteria should be excluded from this study.